Jilin Jian Yisheng Pharmaceutical Co Ltd
Jilin Jian Yisheng Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, wholesale, retail, import, and export of pharmaceutical products in China. The company offers paper packaging products; drugs comprising capsules, injections, tablets, granules, and other drug products; cosmetics; ginseng products; bee products; and food products comprisi… Read more
Jilin Jian Yisheng Pharmaceutical Co Ltd - Asset Resilience Ratio
Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) has an Asset Resilience Ratio of 15.22% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2006–2024)
This chart shows how Jilin Jian Yisheng Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Jilin Jian Yisheng Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥454.04 Million | 15.22% |
| Total Liquid Assets | CN¥454.04 Million | 15.22% |
Asset Resilience Insights
- Good Liquidity Position: Jilin Jian Yisheng Pharmaceutical Co Ltd maintains a healthy 15.22% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Jilin Jian Yisheng Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Jilin Jian Yisheng Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for Jilin Jian Yisheng Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual Asset Resilience Ratio data for Jilin Jian Yisheng Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 15.47% | CN¥459.67 Million | CN¥2.97 Billion | +12.09pp |
| 2023-12-31 | 3.38% | CN¥102.98 Million | CN¥3.05 Billion | +1.36pp |
| 2022-12-31 | 2.02% | CN¥59.84 Million | CN¥2.97 Billion | -0.43pp |
| 2021-12-31 | 2.45% | CN¥70.16 Million | CN¥2.86 Billion | +2.30pp |
| 2017-12-31 | 0.15% | CN¥4.00 Million | CN¥2.65 Billion | -1.10pp |
| 2015-12-31 | 1.25% | CN¥33.00 Million | CN¥2.63 Billion | -2.04pp |
| 2014-12-31 | 3.29% | CN¥82.00 Million | CN¥2.49 Billion | +3.21pp |
| 2006-12-31 | 0.08% | CN¥269.00K | CN¥338.04 Million | -- |